Health Secretary Matt Hancock delivering Downing Street coronavirus press briefing

The transcript discusses the UK's strategy to combat new coronavirus variants. It highlights the effectiveness of existing vaccines in preventing severe illness and mortality, the development of booster jabs, and the expansion of UK vaccine production capacity. A partnership with CureVAC aims to create adaptable vaccines for new strains. The UK has secured an additional 50 million doses to prepare for future challenges. Reducing coronavirus cases is crucial to prevent new variants, and the current hospital and mortality rates, though high, are decreasing.

What is the primary role of existing vaccines in relation to new virus variants?

• To completely eradicate the virus

• To ensure everyone gets infected

• To prevent severe illness and death

• To stop the virus from mutating

What is the purpose of developing booster jabs?

• To replace the existing vaccines

• To target new variants and enhance protection

• To reduce the cost of vaccination

• To increase the number of doses required

What technology is being utilized to rapidly develop vaccines in the UK?

• Herbal medicine

• Traditional vaccine methods

• Cutting-edge M RNA technologies

• Homeopathic remedies

What is the significance of the partnership with Cure VAC?

• To develop vaccines that can be quickly adapted to new strains

• To distribute vaccines globally

• To produce vaccines at a lower cost

• To create a new type of vaccine

Why is reducing new coronavirus cases important?

• To ensure everyone gets infected

• To increase the number of hospitalizations

• To lower the chance of new variants appearing

• To stop the production of vaccines